EC
SNDX icon

EntryPoint Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

EntryPoint Capital’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,090
Closed -$22.4K – 1094
2024
Q2 		$22.4K Sell
1,090
-7,546
-87% -$155K 0.03% 699
2024
Q1 		$206K Buy
8,636
+7,165
+487% +$171K 0.18% 110
2023
Q4 		$31.8K Buy
+1,471
New +$31.8K 0.03% 903